4//SEC Filing
WG Biotech ApS 4
Accession 0001104659-23-122092
CIK 0001722964other
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 5:14 PM ET
Size
7.8 KB
Accession
0001104659-23-122092
Insider Transaction Report
Form 4
WG Biotech ApS
Director10% Owner
Transactions
- Purchase
Common Stock
2023-11-28$5.81/sh+30,671$178,275→ 4,373,392 total - Purchase
Common Stock
2023-11-27$5.49/sh+62,516$343,019→ 4,342,721 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $5.38 to $5.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $5.51 to $6.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
IncorporatedDenmark
Related Parties
1- filerCIK 0001753193
Filing Metadata
- Form type
- 4
- Filed
- Nov 28, 7:00 PM ET
- Accepted
- Nov 29, 5:14 PM ET
- Size
- 7.8 KB